SCHEMBL722846

SCHEMBL722846

CCCCOC(O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LTA4H P09960 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NAAA Q02083 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.40
GPR88 Q9GZN0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28115200 0.94 LMNA (0.50) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL9252653 0.94 LMNA (0.50) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL29211021 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL10430492 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL28403155 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL10618772 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL28706904 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL9750029 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL4850677 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H
SCHEMBL28903655 0.93 NPC1 (0.51) LMNANPC1RAB9ASMN1; SMN2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2809634-A1 METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES General Electric Company (US) 2014-12-10 EP claimed
US-8901362-B2 Methods and compositions for styrene inhibition via in situ generation of quinone methides GENERAL ELECTRIC COMPANY (US) 2014-12-02 US claimed
WO-2013116611-A1 METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES GENERAL ELECTRIC COMPANY (US) 2013-08-08 WO claimed
US-20130204053-A1 METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES GENERAL ELECTRIC COMPANY (US) 2013-08-08 US claimed
US-20030091608-A1 Collar containing a novel gel formulation to control arthropod infestation of animals GUTIERREZ LUIS (US) 2003-05-15 US claimed
EP-0979605-B1 Collar containing a novel gel formulation to control arthropod infestation of animals PFIZER PROD INC (US) 2003-04-02 EP claimed
US-20020044955-A1 Collar containing a novel gel formulation to control arthropod infestation of animals GUTIERREZ LUIS (US) 2002-04-18 US claimed
US-6372242-B1 Collar containing a novel gel formulation to control arthropod infestation of animals PFIZER INC 2002-04-16 US claimed
EP-0979605-A1 Collar containing a novel gel formulation to control arthropod infestation of animals Pfizer Products Inc. (US) 2000-02-16 EP claimed
WO-2024160732-A1 SOFT SURFACE CLEANING COMPOSITIONS RECKITT BENCKISER LLC (US) 2024-08-08 WO disclosed
WO-2024133098-A1 RINSE AID RECKITT BENCKISER FINISH B.V. (NL) 2024-06-27 WO disclosed
WO-2024133097-A1 LIQUID RINSE AID COMPOSITIONS RECKITT BENCKISER FINISH B.V. (NL) 2024-06-27 WO disclosed
EP-3239261-B1 METHOD FOR PRODUCING AN ADHESIVE COMPOSITION AND A LAMINATE TOYO INK SC HOLDINGS CO LTD (JP) 2023-11-29 EP disclosed
CN-107406744-B Method for producing adhesive composition and method for producing laminate 东洋油墨SC控股株式会社 2020-06-23 CN disclosed
US-6372242-B1 Collar containing a novel gel formulation to control arthropod infestation of animals PFIZER INC 2002-04-16 US disclosed
EP-1004621-A1 GAMMA-RAY STABILIZER AND THERMOPLASTIC POLYMER COMPOSITION CONTAINING THE SAME TEIJIN LIMITED (JP) 2000-05-31 EP disclosed
EP-0979605-A1 Collar containing a novel gel formulation to control arthropod infestation of animals Pfizer Products Inc. (US) 2000-02-16 EP disclosed
US-4172068-A POLYOL, POLYISOCYANATE; ACETAL OR KETAL AS SOLVENT INTERNATIONAL MINERALS & CHEMICAL CORPORATION (US) 1979-10-23 US disclosed
US-4116916-A BINDER, PHENOL-FORMALDEHYDE RESIN, POLYISOCYANATE, SOLVENT INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1978-09-26 US disclosed
US-4051092-A CURABLE RESIN, POLYISOCYANATE INTERNATIONAL MINERALS & CHEMICAL CORPORATION (US) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130204053-A1 METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES ADH1A, ADH1C, ADH5 LMNA 2195/4885NPC1 4772/4885RAB9A 2803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.